Search Results

There are 51035 results for: content related to: Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89 Zr-labeled cetuximab in mice

  1. You have free access to this content
    Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Zu-Yao Yang, Li Liu, Chen Mao, Xin-Yin Wu, Ya-Fang Huang, Xue-Feng Hu and Jin-Ling Tang

    Published Online : 17 NOV 2014, DOI: 10.1002/14651858.CD009948.pub2

  2. You have full text access to this OnlineOpen article
    Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 65–74, Uma Raju, David P. Molkentine, David R. Valdecanas, Amit Deorukhkar, Kathryn A. Mason, Thomas A. Buchholz, Raymond E. Meyn, Kie-Kian Ang and Heath Skinner

    Version of Record online : 29 OCT 2014, DOI: 10.1002/cam4.345

  3. You have full text access to this Open Access content
    Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 2062–2069, Junya Fukai, Kazuto Nishio, Toru Itakura and Fumiaki Koizumi

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00945.x

  4. The role of cetuximab as first-line treatment of colorectal liver metastases

    HPB

    Volume 15, Issue 1, January 2013, Pages: 11–17, Claire Jones, Mark A. Taylor and Billy McWilliams

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1477-2574.2012.00591.x

  5. You have free access to this content
    Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody–drug conjugates by cholesterol sequestration

    International Journal of Cancer

    Volume 136, Issue 1, 1 January 2015, Pages: 182–194, Yang Chen, Guanghua Liu, Lifang Guo, Hui Wang, Yan Fu and Yongzhang Luo

    Version of Record online : 14 MAY 2014, DOI: 10.1002/ijc.28950

  6. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  7. Cetuximab-based therapy vs noncetuximab therapy in advanced or metastatic colorectal cancer: a meta-analysis of seven randomized controlled trials

    Colorectal Disease

    Volume 12, Issue 5, May 2010, Pages: 399–406, L. Liu, Y. Cao, A. Tan, C. Liao, Z. Mo and F. Gao

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1463-1318.2009.01916.x

  8. Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model

    Small

    Volume 9, Issue 24, December 20, 2013, Pages: 4221–4236, Nour Karra, Taher Nassar, Alina Nemirovski Ripin, Ouri Schwob, Jürgen Borlak and Simon Benita

    Version of Record online : 21 JUL 2013, DOI: 10.1002/smll.201301417

  9. You have full text access to this OnlineOpen article
    A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils

    Cancer Medicine

    Volume 5, Issue 6, June 2016, Pages: 1004–1012, Takuya Iwamoto, Akiharu Okamoto, Hajime Ishinaga, Kasumi Shimizu, Alberto A. Gayle, Naoya Arai, Kazuhiko Takeuchi and Masahiro Okuda

    Version of Record online : 16 FEB 2016, DOI: 10.1002/cam4.658

  10. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    David Lok Hang Chan, Eva Segelov, Rachel SH Wong, Annabel Smith, Rebecca A Herbertson, Bob T. Li, Niall Tebbutt, Timothy Price and Nick Pavlakis

    Published Online : 27 JUN 2017, DOI: 10.1002/14651858.CD007047.pub2

  11. You have free access to this content
    KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 714–721, Chen Mao, Ya-Fang Huang, Zu-Yao Yang, Da-Yong Zheng, Jin-Zhang Chen and Jin-Ling Tang

    Version of Record online : 12 SEP 2012, DOI: 10.1002/cncr.27804

  12. You have free access to this content
    A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment

    International Journal of Cancer

    Volume 131, Issue 4, 15 August 2012, Pages: 956–969, Hongzheng Zhang, Sujin Yun, Thil D. Batuwangala, Michael Steward, Steve D. Holmes, Lin Pan, Mourad Tighiouart, Hyung Ju C. Shin, Lydia Koenig, Wungki Park, Daniel Rycroft, Sreenivas Nannapaneni, Yuxiang Wang, Zhuo (Georgia) Chen and Dong M. Shin

    Version of Record online : 19 NOV 2011, DOI: 10.1002/ijc.26427

  13. You have full text access to this OnlineOpen article
    A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1493–1501, Douglas Adkins, Jessica Ley, Farrokh Dehdashti, Marilyn J. Siegel, Tanya M. Wildes, Loren Michel, Kathryn Trinkaus and Barry A. Siegel

    Version of Record online : 1 AUG 2014, DOI: 10.1002/cam4.294

  14. You have free access to this content
    Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma

    International Journal of Cancer

    Volume 120, Issue 4, 15 February 2007, Pages: 781–787, Yoshihiko Kawaguchi, Koji Kono, Kousaku Mimura, Hidemitsu Sugai, Hidenori Akaike and Hideki Fujii

    Version of Record online : 9 NOV 2006, DOI: 10.1002/ijc.22370

  15. Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases

    Journal of Cellular Physiology

    Volume 208, Issue 2, August 2006, Pages: 344–353, Maria Pia Morelli, Tina Cascone, Teresa Troiani, Concetta Tuccillo, Roberto Bianco, Nicola Normanno, Marco Romano, Bianca Maria Veneziani, Gabriella Fontanini, S. Gail Eckhardt, Sabino De Pacido, Giampaolo Tortora and Fortunato Ciardiello

    Version of Record online : 10 MAY 2006, DOI: 10.1002/jcp.20666

  16. Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 6, December 2014, Pages: 652–660, Céline Chu, Chadi Abbara, Mahamadou Tandia, Mélanie Polrot, Patrick Gonin, Robert Farinotti and Laurence Bonhomme-Faivre

    Version of Record online : 16 APR 2014, DOI: 10.1111/fcp.12071

  17. You have full text access to this Open Access content
    Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1717–1723, Norio Kondo, Mamoru Tsukuda, Takahide Taguchi, Kouichi Nakazaki, Atsuko Sakakibara, Hideaki Takahashi, Gabor Toth and Goshi Nishimura

    Version of Record online : 3 JUL 2011, DOI: 10.1111/j.1349-7006.2011.01999.x

    Corrected by:

    Correction: Correction

    Vol. 105, Issue 11, 1518, Version of Record online: 20 NOV 2014

  18. You have full text access to this Open Access content
    Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity

    Cancer Science

    Volume 99, Issue 7, July 2008, Pages: 1471–1478, Masayasu Hara, Hayao Nakanishi, Kunio Tsujimura, Makoto Matsui, Yasushi Yatabe, Tadao Manabe and Masae Tatematsu

    Version of Record online : 16 APR 2008, DOI: 10.1111/j.1349-7006.2008.00821.x

  19. 90Y/177Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 59, Issue 9, July 2016, Pages: 354–363, Rubel Chakravarty, Sudipta Chakraborty, Haladhar Dev Sarma, K. V. Vimalnath Nair, Ardhi Rajeswari and Ashutosh Dash

    Version of Record online : 5 JUN 2016, DOI: 10.1002/jlcr.3413

  20. You have free access to this content
    Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model

    International Journal of Cancer

    Volume 129, Issue 4, 15 August 2011, Pages: 870–878, Bianca A.W. Hoeben, Janneke D.M. Molkenboer-Kuenen, Wim J.G. Oyen, Wenny J.M. Peeters, Johannes H.A.M. Kaanders, Johan Bussink and Otto C. Boerman

    Version of Record online : 1 DEC 2010, DOI: 10.1002/ijc.25727